MAR vs VRT: Which Is the Better Buy?

Side-by-side comparison of Marriott International, Inc. and Vertiv Holdings Co β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-26.
Marriott International, Inc. Β· Consumer Cyclical
$334.97
+20.6% upside to fair value
Med Conviction Grade C
VS
Vertiv Holdings Co Β· Industrials
$253.28
+8.2% upside to fair value
Med Conviction Grade C High Quality
QuantHub Verdict
MAR has more upside to fair value (+20.6%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric MAR VRT
Current Price $334.97 $253.28
Fair Value Estimate $403.81 $274.15
Upside to Fair Value +20.6% +8.2%
Market Cap $87.3B $97.5B
Forward P/E β€” β€”
EV / EBITDA 22.2x 38.8x
Price / Sales 3.2x 8.5x
Price / FCF 28.7x 33.3x
Revenue Growth YoY +4.8% +24.1%
Gross Margin 20.2% 37.5%
Operating Margin 15.8% 19.1%
Return on Equity -66.7% 42.1%
Dividend Yield 0.84% 0.1%
FCF Yield 3.48% 3.0%
Analyst Consensus Hold Strong Buy
Investment Thesis
MAR β€” Marriott International, Inc.
Marriott International is a global asset-light hotel franchisor and manager whose 10,082-property, 1.814 million-room system, 629,000-room development pipeline, broad brands, and more than 295 million Bonvoy members support durable fee-led economics. Business quality is tempered by cyclicality, competitive owner incentives, and $16.915 billion of debt, while reported ROE is negative 66.7%. In the…
VRT β€” Vertiv Holdings Co
Vertiv Holdings Co is a global provider of critical digital infrastructure for data centers, communication networks, and industrial applications, spanning AC and DC power management, thermal cooling, integrated rack systems, and lifecycle services under brands including Liebert, NetSure, Geist, and Avocent, with roughly 34,000 employees and a global footprint across the Americas, Asia Pacific, an…
Accumulation Zones
Metric MAR VRT
Zone Low $302.86 $205.61
Zone High $343.24 $233.03
In Buy Zone? Yes No
← MAR Research    VRT Research β†’    All Research